thumbnail

Limited human infection due to recombinant raccoon pox virus

Vaccine

By:
, , , , ,

Links

Abstract

A laboratory accident resulted in human exposure to a recombinant raccoon poxvirus (RCN) developed as a vaccine vector for antigens of Yersinia pestis for protection of wild rodents (and other animals) against plague. Within 9 days, the patient developed a small blister that healed within 4 weeks. Raccoon poxvirus was cultured from the lesion, and the patient developed antibody to plague antigen (F1) and RCN. This is the first documented case of human exposure to RCN.

Additional Publication Details

Publication type:
Article
Publication Subtype:
Journal Article
Title:
Limited human infection due to recombinant raccoon pox virus
Series title:
Vaccine
Volume
22
Issue:
21-22
Year Published:
2004
Language:
English
Contributing office(s):
National Wildlife Health Center
Description:
p. 2757-2760
Larger Work Type:
Article
Larger Work Subtype:
Journal Article
First page:
2757
Last page:
2760
Number of Pages:
4